Video Experimental Relacionado
Updated: May 13, 2026
10:27
Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells
Published on: March 9, 2012
El supresor del tumor PP2A Abeta regula la RalA GTPasa
Anna A Sablina1, Wen Chen, Jason D Arroyo
1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
Cell
|June 2, 2007
Resumen
La subunidad de la proteína fosfatasa 2A (PP2A) Abeta actúa como supresor de tumores. Las mutaciones asociadas al cáncer en PP2A Abeta inactivan su función supresora de tumores al prevenir la inactivación de RalA.
Área de la Ciencia:
- Biología Molecular Biología Molecular
- Oncología Oncología.
- Biología celular Biología celular.
Sus antecedentes:
- La serina-treonina proteína fosfatasa 2A (PP2A) es una familia de enzimas clave que regula las vías de señalización celular.
- Las mutaciones bialélicas en la subunidad PP2A Abeta se observan en varios tumores humanos, pero su impacto funcional en la transformación celular no está claro.
Objetivo del estudio:
- Para investigar las consecuencias funcionales de las mutaciones PP2A Abeta asociadas al cáncer en la transformación celular.
- Para determinar el papel de PP2A Abeta en la regulación de la pequeña GTPasa RalA.
Principales métodos:
- La supresión de la expresión génica de PP2A Abeta en células humanas inmortalizadas.
- Análisis de la transformación celular y el fenotipo tumorigénico.
- Co-inmunoprecipitación para evaluar la formación de complejos proteicos entre PP2A Abeta y RalA.
- Ensayos in vitro de fosfatasa para determinar el estado de fosforilación de RalA.
Principales resultados:
- La supresión de la expresión de PP2A Abeta indujo un estado tumorigénico en células humanas inmortalizadas.
- Los mutantes Abeta PP2A asociados al cáncer no invirtieron el fenotipo tumorigénico, funcionando como alelos nulos.
- El tipo salvaje PP2A Abeta, pero no los mutantes del cáncer, formaron un complejo con RalA.
- PP2A Los complejos Abeta desfosforilan RalA en sitios específicos, lo que lleva a su inactivación.
Conclusiones:
- PP2A Abeta funciona como un gen supresor de tumores.
- PP2A Abeta regula la transformación celular mediante la inactivación de la pequeña GTPasa RalA.
- Las mutaciones asociadas al cáncer en PP2A Abeta interrumpen su actividad supresora de tumores al afectar la regulación de RalA.
Videos de Conceptos Relacionados
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
01:14Rab Proteins
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
01:24Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...